首页 > 最新文献

Sexual Medicine最新文献

英文 中文
General and transgender-specific quality of life in trans persons assigned female at birth: validation of the Essen Transgender Quality of Life-Inventory. 出生时被指定为女性的跨性别者的一般生活质量和跨性别特有的生活质量:埃森跨性别生活质量量表的验证。
IF 2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-08-27 eCollection Date: 2025-08-01 DOI: 10.1093/sexmed/qfaf054
Sophia Rücker, Jochen Heß, Jil Beckord, Mirko Fasel, Alexander Bäuerle, Johannes Fuss, Julia Bohr, Cordula Lang, Jens Wallmichrath, Andreas Wolter, Sonia Maria Fertsch, Stefan Langer, Madeleine Fink, Martin Teufel
<p><strong>Background: </strong>Transgenderism has always been part of society, with some individuals experiencing gender dysphoria (GD). When present, it is associated with diminished quality of life (QoL), along with minority stress, compared to the cisgender population.</p><p><strong>Aim: </strong>The primary objective of this study was the validation of the Essen Transgender Quality of Life-Inventory (ETLI), originally designed for assigned male at birth (AMAB) transgender individuals, in the German population on those assigned female at birth (AFAB).</p><p><strong>Methods: </strong>A multi-center survey study with 139 participants was conducted. The assessment encompassed sociodemographic and medical data, and the following instruments: ETLI (transgender-specific QoL), F-SozU (social support), PHQ-8 (depression), GAD-7 (anxiety), and the Belief in a Just World questionnaire. Visual analogue scales (VAS) assessed physical and mental health, general QoL, and social environment quality. Following the Strengthening the Reporting of Observational Studies in Epidemiology guidelines, descriptive statistics, exploratory factor analysis (EFA), confirmatory factor analysis (CFA), reliability analysis, and intercorrelation analysis of ETLI subscales were performed, along with bivariate correlations with related instruments proximal and distal to the questionnaire to assess construct and criterion validity.</p><p><strong>Outcomes: </strong>Outcomes included factor structure, reliability, as well as construct and criterion validity of the ETLI.</p><p><strong>Results: </strong>The initial CFA, based on previous work, indicated a suboptimal factor structure, leading to the conduction of an EFA, which suggested a revised factor model. A subsequent CFA confirmed a satisfactory model fit for the proposed structure. All ETLI scales reached high reliability coefficients. Intercorrelation analysis revealed moderate to high associations among subscales. Convergent validity was confirmed by significant correlations of ETLI subscales with the PHQ-8, GAD-7, and F-SozU questionnaires. Discriminant validity was partially supported through the Belief in a Just World questionnaire. Criterion validity was affirmed using the VAS regarding general QoL, mental and physical health, and social environment quality.</p><p><strong>Clinical implications: </strong>Due to its confirmed validity and reliability as well as the lack of viable alternatives, the ETLI provides healthcare professionals with a robust tool to assess QoL issues specific to this population, facilitating more targeted and effective interventions to improve QoL.</p><p><strong>Strengths and limitations: </strong>Strengths are the inclusion of a heterogeneous age range and the use of advanced statistical analyses. However, recruitment from specific clinics and a limited sample size restrict the generalizability of our study.</p><p><strong>Conclusion: </strong>The study substantiates the ETLI's construct and crite
背景:跨性别主义一直是社会的一部分,一些个体经历着性别焦虑(GD)。与顺性人群相比,当出现时,它与生活质量(QoL)下降以及少数民族压力有关。目的:本研究的主要目的是验证埃森跨性别者生活质量量表(ETLI)的有效性,该量表最初是为德国人口中出生时被指定为男性(AMAB)的跨性别者设计的,在出生时被指定为女性(AFAB)的跨性别者设计的。方法:采用多中心调查方法,共139人。评估包括社会人口统计学和医学数据,以及以下工具:ETLI(跨性别特定的生活质量)、F-SozU(社会支持)、PHQ-8(抑郁)、GAD-7(焦虑)和对公正世界的信念问卷。视觉模拟量表(VAS)评估身心健康、总体生活质量和社会环境质量。根据《加强流行病学观察性研究报告指南》,对ETLI子量表进行描述性统计、探索性因子分析(EFA)、验证性因子分析(CFA)、信度分析和相关分析,并与问卷近端和远端相关工具进行双变量相关性分析,以评估结构和标准效度。结果:结果包括量表的因子结构、信度、量表的结构和效度。结果:基于先前的工作,最初的CFA表明因子结构不理想,导致EFA的传导,这表明了一个修订的因子模型。随后的CFA证实了一个令人满意的模型适合所提议的结构。所有ETLI量表均达到较高的信度系数。相关分析显示各分量表间存在中高相关性。ETLI量表与PHQ-8、GAD-7和F-SozU问卷具有显著的相关性,证实了其收敛效度。通过“公正世界信念”问卷,部分地支持了判别效度。采用VAS对总体生活质量、身心健康、社会环境质量等方面进行效度评价。临床意义:由于其确认的有效性和可靠性以及缺乏可行的替代方案,ETLI为医疗保健专业人员提供了一个强大的工具来评估特定于该人群的生活质量问题,促进更有针对性和更有效的干预措施,以改善生活质量。优点和局限性:优点是包含了不同年龄范围和使用先进的统计分析。然而,来自特定诊所的招募和有限的样本量限制了我们研究的普遍性。结论:本研究在AFAB人群中证实了ETLI的结构和标准效度,显示了令人满意的信度,并通过随后的CFA验证了修订后的因素结构。
{"title":"General and transgender-specific quality of life in trans persons assigned female at birth: validation of the Essen Transgender Quality of Life-Inventory.","authors":"Sophia Rücker, Jochen Heß, Jil Beckord, Mirko Fasel, Alexander Bäuerle, Johannes Fuss, Julia Bohr, Cordula Lang, Jens Wallmichrath, Andreas Wolter, Sonia Maria Fertsch, Stefan Langer, Madeleine Fink, Martin Teufel","doi":"10.1093/sexmed/qfaf054","DOIUrl":"10.1093/sexmed/qfaf054","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Transgenderism has always been part of society, with some individuals experiencing gender dysphoria (GD). When present, it is associated with diminished quality of life (QoL), along with minority stress, compared to the cisgender population.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Aim: &lt;/strong&gt;The primary objective of this study was the validation of the Essen Transgender Quality of Life-Inventory (ETLI), originally designed for assigned male at birth (AMAB) transgender individuals, in the German population on those assigned female at birth (AFAB).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A multi-center survey study with 139 participants was conducted. The assessment encompassed sociodemographic and medical data, and the following instruments: ETLI (transgender-specific QoL), F-SozU (social support), PHQ-8 (depression), GAD-7 (anxiety), and the Belief in a Just World questionnaire. Visual analogue scales (VAS) assessed physical and mental health, general QoL, and social environment quality. Following the Strengthening the Reporting of Observational Studies in Epidemiology guidelines, descriptive statistics, exploratory factor analysis (EFA), confirmatory factor analysis (CFA), reliability analysis, and intercorrelation analysis of ETLI subscales were performed, along with bivariate correlations with related instruments proximal and distal to the questionnaire to assess construct and criterion validity.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Outcomes: &lt;/strong&gt;Outcomes included factor structure, reliability, as well as construct and criterion validity of the ETLI.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The initial CFA, based on previous work, indicated a suboptimal factor structure, leading to the conduction of an EFA, which suggested a revised factor model. A subsequent CFA confirmed a satisfactory model fit for the proposed structure. All ETLI scales reached high reliability coefficients. Intercorrelation analysis revealed moderate to high associations among subscales. Convergent validity was confirmed by significant correlations of ETLI subscales with the PHQ-8, GAD-7, and F-SozU questionnaires. Discriminant validity was partially supported through the Belief in a Just World questionnaire. Criterion validity was affirmed using the VAS regarding general QoL, mental and physical health, and social environment quality.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Clinical implications: &lt;/strong&gt;Due to its confirmed validity and reliability as well as the lack of viable alternatives, the ETLI provides healthcare professionals with a robust tool to assess QoL issues specific to this population, facilitating more targeted and effective interventions to improve QoL.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Strengths and limitations: &lt;/strong&gt;Strengths are the inclusion of a heterogeneous age range and the use of advanced statistical analyses. However, recruitment from specific clinics and a limited sample size restrict the generalizability of our study.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;The study substantiates the ETLI's construct and crite","PeriodicalId":21782,"journal":{"name":"Sexual Medicine","volume":"13 4","pages":"qfaf054"},"PeriodicalIF":2.0,"publicationDate":"2025-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12381761/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144967546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Whole exome sequencing analysis of susceptibility loci in transgender individuals. 跨性别人群易感位点的全外显子组测序分析。
IF 2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-08-22 eCollection Date: 2025-08-01 DOI: 10.1093/sexmed/qfaf062
Na Liu, Jingyi Bai, Nan Huang, Yi Xu, Xiangyun Long, Xinyi Hu, Jiaxin Wu, Fei Liu, Zheng Lu
<p><strong>Background: </strong>Genetic factors contributing to sex-associated dimorphic brain development may also underlie gender identity-related anxiety disorders.</p><p><strong>Aim: </strong>To establish a high-throughput whole-exome sequencing (WES) and bioinformatics pipeline for identifying rare variants in sex-dimorphic neural pathways and explore their association with gender identity-related anxiety.</p><p><strong>Methods: </strong>Peripheral genomic DNA was collected from 23 patients (13 Assigned male at birth (AMAB), 10 Assigned female at birth (AFAB)) presenting with gender identity-related anxiety at Shanghai Mental Health Centre between March 2020 and February 2022. WES libraries were prepared and sequenced to an average depth of 100×. Raw reads underwent stringent quality control, alignment, variant calling, and annotation against public databases (gnomAD, ClinVar). Rare (minor allele frequency [MAF] < 1%) high-confidence variants were filtered to focus on exonic, splice-site, and insertion and deletion (indel) events. Candidate genes were subjected to Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment and Gene Ontology (GO) analyses to identify overrepresented neural development pathways, with particular emphasis on estrogen receptor-mediated signaling.</p><p><strong>Outcome: </strong>A total of 479 rare, potentially pathogenic variants across 19 estrogen receptor-mediated neurodevelopmental genes were identified for further validation.</p><p><strong>Results: </strong>After quality control, 266 265 high-confidence variants were retained; of 217 757 exomic calls, 48 508 (22.3%) were exonic (49.8% nonsynonymous), including 4.1% splice-site, 225 missense, 27 nonsense, 43 frameshift, and various indels. KEGG analysis highlighted significant enrichment in axon guidance signaling, while GO terms pointed to neuronal projection and synaptic assembly. Nineteen genes within the estrogen receptor pathway harbored rare deleterious variants, suggesting disruptions in sex hormone-driven neural differentiation.</p><p><strong>Clinical translation: </strong>This WES-based framework enables the identification of novel candidate loci for diagnostic panels and may inform personalized interventions for gender identity-related anxiety.</p><p><strong>Strengths and limitations: </strong>This study leveraged high-depth whole-exome sequencing, stringent bioinformatics filtering, and a pathway-focused approach to pinpoint rare variants in sex-dimorphic neurodevelopmental genes; however, its small sample size, lack of functional validation, potential population stratification bias, and cross-sectional design limit causal inference.</p><p><strong>Conclusion: </strong>Our integrated WES and bioinformatics pipeline uncovers rare variants in estrogen receptor-mediated neurodevelopmental genes, providing new insights into the genetic architecture of sex-dimorphic brain development and its role in gender identity-related anxiety.</p><p><strong>Stu
背景:促进性别相关的二态脑发育的遗传因素也可能是性别认同相关焦虑症的基础。目的:建立高通量全外显子组测序(WES)和生物信息学管道,用于鉴定性别二态神经通路的罕见变异,并探讨其与性别认同相关焦虑的关系。方法:收集2020年3月至2022年2月在上海精神卫生中心就诊的23例性别认同相关焦虑患者的外周基因组DNA(13例出生时为男性(AMAB), 10例出生时为女性(AFAB))。制备WES文库,测序平均深度为100×。原始读取经过严格的质量控制、比对、变量调用和针对公共数据库(gnomAD、ClinVar)的注释。结果:在19个雌激素受体介导的神经发育基因中,共有479个罕见的潜在致病变异被鉴定出来,以进一步验证。结果:经质量控制,保留高置信度变异266 265个;在217 757个外显子呼叫中,外显子呼叫48 508个(22.3%)(非同义呼叫49.8%),其中剪接位点呼叫4.1%,错义呼叫225个,无义呼叫27个,移码呼叫43个,以及各种索引。KEGG分析强调了轴突引导信号的显著富集,而GO术语则指向神经元投射和突触组装。雌激素受体通路中的19个基因含有罕见的有害变异,表明性激素驱动的神经分化受到破坏。临床翻译:这种基于wes的框架能够为诊断小组识别新的候选基因座,并可能为性别认同相关焦虑的个性化干预提供信息。优势和局限性:本研究利用高深度全外显子组测序、严格的生物信息学过滤和以途径为重点的方法来查明性别二态神经发育基因中的罕见变异;然而,其样本量小,缺乏功能验证,潜在的人群分层偏差和横断面设计限制了因果推理。结论:我们整合的WES和生物信息学管道揭示了雌激素受体介导的神经发育基因的罕见变异,为性别二态脑发育的遗传结构及其在性别认同相关焦虑中的作用提供了新的见解。研究注册:本文已在ISRCTN注册中心https://www.isrctn.com/ISRCTN18336816注册。18336816)在观察性研究记录下。
{"title":"Whole exome sequencing analysis of susceptibility loci in transgender individuals.","authors":"Na Liu, Jingyi Bai, Nan Huang, Yi Xu, Xiangyun Long, Xinyi Hu, Jiaxin Wu, Fei Liu, Zheng Lu","doi":"10.1093/sexmed/qfaf062","DOIUrl":"10.1093/sexmed/qfaf062","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Genetic factors contributing to sex-associated dimorphic brain development may also underlie gender identity-related anxiety disorders.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Aim: &lt;/strong&gt;To establish a high-throughput whole-exome sequencing (WES) and bioinformatics pipeline for identifying rare variants in sex-dimorphic neural pathways and explore their association with gender identity-related anxiety.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Peripheral genomic DNA was collected from 23 patients (13 Assigned male at birth (AMAB), 10 Assigned female at birth (AFAB)) presenting with gender identity-related anxiety at Shanghai Mental Health Centre between March 2020 and February 2022. WES libraries were prepared and sequenced to an average depth of 100×. Raw reads underwent stringent quality control, alignment, variant calling, and annotation against public databases (gnomAD, ClinVar). Rare (minor allele frequency [MAF] &lt; 1%) high-confidence variants were filtered to focus on exonic, splice-site, and insertion and deletion (indel) events. Candidate genes were subjected to Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment and Gene Ontology (GO) analyses to identify overrepresented neural development pathways, with particular emphasis on estrogen receptor-mediated signaling.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Outcome: &lt;/strong&gt;A total of 479 rare, potentially pathogenic variants across 19 estrogen receptor-mediated neurodevelopmental genes were identified for further validation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;After quality control, 266 265 high-confidence variants were retained; of 217 757 exomic calls, 48 508 (22.3%) were exonic (49.8% nonsynonymous), including 4.1% splice-site, 225 missense, 27 nonsense, 43 frameshift, and various indels. KEGG analysis highlighted significant enrichment in axon guidance signaling, while GO terms pointed to neuronal projection and synaptic assembly. Nineteen genes within the estrogen receptor pathway harbored rare deleterious variants, suggesting disruptions in sex hormone-driven neural differentiation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Clinical translation: &lt;/strong&gt;This WES-based framework enables the identification of novel candidate loci for diagnostic panels and may inform personalized interventions for gender identity-related anxiety.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Strengths and limitations: &lt;/strong&gt;This study leveraged high-depth whole-exome sequencing, stringent bioinformatics filtering, and a pathway-focused approach to pinpoint rare variants in sex-dimorphic neurodevelopmental genes; however, its small sample size, lack of functional validation, potential population stratification bias, and cross-sectional design limit causal inference.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Our integrated WES and bioinformatics pipeline uncovers rare variants in estrogen receptor-mediated neurodevelopmental genes, providing new insights into the genetic architecture of sex-dimorphic brain development and its role in gender identity-related anxiety.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Stu","PeriodicalId":21782,"journal":{"name":"Sexual Medicine","volume":"13 4","pages":"qfaf062"},"PeriodicalIF":2.0,"publicationDate":"2025-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12371408/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144967497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between repeat number polymorphisms of sex hormone-related genes and gender phenotype variations in university students. 大学生性激素相关基因重复数多态性与性别表型变异的关系
IF 2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-08-17 eCollection Date: 2025-08-01 DOI: 10.1093/sexmed/qfaf060
Mizuho Igarashi, Yuko Katoh-Fukui, Atsushi Hattori, Kyongsun Pak, Shoko Sasaki, Maki Fukami

Background: Although common repeat number polymorphisms in 3 hormone-related genes (AR, CYP19A1, and ESR2) have been implicated in the variations in several sexually dimorphic phenotypes, their contributions to the variations in gender identity (GI) and sexual orientation (SO) remain to be clarified.

Aim: To clarify the possible association between the repeat number polymorphisms and gender phenotype variations in the general population.

Methods: We used paper-based questionnaires to select 80 individuals with atypical gender phenotypes (the case group) and 114 control individuals (the control group) from 736 university students. The case group was further divided into two subgroups: one consisted of individuals with low GI scores (the atypical GI subgroup), and the other consisted of individuals with non-heterosexual orientation (the atypical SO subgroup). Repeat numbers of the longer and shorter alleles in each participant (Alleles 1 and 2) were examined through microsatellite analysis. Repeat numbers of AR in females were adjusted for the X chromosome inactivation status.

Outcomes: We examined the statistical differences in the repeat numbers between the case and control groups, and between each subgroup and the control group.

Results: The overall differences between the case and control groups and between each subgroup and the control group were small. However, the repeat numbers of AR in males of the case group were larger than those of the control group (P = 0.049), and the repeat numbers of ESR2 Allele 1 were larger in males of the atypical GI subgroup than in those of the control group (P = 0.046). In addition, females in the atypical SO subgroup had smaller repeat numbers of CYP19A1 Allele 2 than control females (P = 0.011).

Clinical implications: These results indicate the complex genetic basis of gender phenotype variations.

Strengths & limitations: This is the first study that addresses the possible association between common polymorphisms in hormone-related genes and gender phenotypes in the general population. Given the small number of our subjects and the modest differences in the repeat numbers between the case and control groups, our results await further validation.

Conclusion: The results indicate that the contribution of repeat number polymorphisms of the 3 genes to gender phenotype variations in the general population is small, although the repeat numbers of AR and ESR2 are potentially associated with atypical gender phenotypes in males.

背景:虽然3个激素相关基因(AR、CYP19A1和ESR2)的常见重复数多态性与几种两性二态表型的变异有关,但它们对性别认同(GI)和性取向(SO)变异的影响仍有待阐明。目的:阐明普通人群重复数多态性与性别表型变异之间的可能联系。方法:采用纸质问卷调查的方法,从736名大学生中抽取80名非典型性别表型个体(病例组)和114名对照个体(对照组)。病例组进一步分为两个亚组:一个由低GI评分的个体组成(非典型GI亚组),另一个由非异性恋取向的个体组成(非典型SO亚组)。通过微卫星分析检测每个参与者中较长和较短等位基因(等位基因1和2)的重复数。根据X染色体失活状态调整女性AR重复数。结果:我们检查了病例组与对照组之间、每个亚组与对照组之间重复次数的统计学差异。结果:病例组与对照组、各亚组与对照组总体差异较小。但病例组男性AR重复数高于对照组(P = 0.049),非典型GI亚组男性ESR2等位基因1重复数高于对照组(P = 0.046)。此外,非典型SO亚组女性CYP19A1等位基因2的重复数少于对照组女性(P = 0.011)。临床意义:这些结果表明性别表型变异的复杂遗传基础。优势与局限性:这是第一个在普通人群中探讨激素相关基因的常见多态性与性别表型之间可能存在关联的研究。鉴于我们的研究对象数量较少,而且病例组和对照组之间重复次数的差异不大,我们的结果有待进一步验证。结论:虽然AR和ESR2基因的重复数可能与男性非典型性别表型相关,但3个基因的重复数多态性对普通人群性别表型变异的贡献较小。
{"title":"Association between repeat number polymorphisms of sex hormone-related genes and gender phenotype variations in university students.","authors":"Mizuho Igarashi, Yuko Katoh-Fukui, Atsushi Hattori, Kyongsun Pak, Shoko Sasaki, Maki Fukami","doi":"10.1093/sexmed/qfaf060","DOIUrl":"10.1093/sexmed/qfaf060","url":null,"abstract":"<p><strong>Background: </strong>Although common repeat number polymorphisms in 3 hormone-related genes (<i>AR</i>, <i>CYP19A1</i>, and <i>ESR2</i>) have been implicated in the variations in several sexually dimorphic phenotypes, their contributions to the variations in gender identity (GI) and sexual orientation (SO) remain to be clarified.</p><p><strong>Aim: </strong>To clarify the possible association between the repeat number polymorphisms and gender phenotype variations in the general population.</p><p><strong>Methods: </strong>We used paper-based questionnaires to select 80 individuals with atypical gender phenotypes (the case group) and 114 control individuals (the control group) from 736 university students. The case group was further divided into two subgroups: one consisted of individuals with low GI scores (the atypical GI subgroup), and the other consisted of individuals with non-heterosexual orientation (the atypical SO subgroup). Repeat numbers of the longer and shorter alleles in each participant (Alleles 1 and 2) were examined through microsatellite analysis. Repeat numbers of <i>AR</i> in females were adjusted for the X chromosome inactivation status.</p><p><strong>Outcomes: </strong>We examined the statistical differences in the repeat numbers between the case and control groups, and between each subgroup and the control group.</p><p><strong>Results: </strong>The overall differences between the case and control groups and between each subgroup and the control group were small. However, the repeat numbers of <i>AR</i> in males of the case group were larger than those of the control group (<i>P</i> = 0.049), and the repeat numbers of <i>ESR2</i> Allele 1 were larger in males of the atypical GI subgroup than in those of the control group (<i>P</i> = 0.046). In addition, females in the atypical SO subgroup had smaller repeat numbers of <i>CYP19A1</i> Allele 2 than control females (<i>P</i> = 0.011).</p><p><strong>Clinical implications: </strong>These results indicate the complex genetic basis of gender phenotype variations.</p><p><strong>Strengths & limitations: </strong>This is the first study that addresses the possible association between common polymorphisms in hormone-related genes and gender phenotypes in the general population. Given the small number of our subjects and the modest differences in the repeat numbers between the case and control groups, our results await further validation.</p><p><strong>Conclusion: </strong>The results indicate that the contribution of repeat number polymorphisms of the 3 genes to gender phenotype variations in the general population is small, although the repeat numbers of <i>AR</i> and <i>ESR2</i> are potentially associated with atypical gender phenotypes in males.</p>","PeriodicalId":21782,"journal":{"name":"Sexual Medicine","volume":"13 4","pages":"qfaf060"},"PeriodicalIF":2.0,"publicationDate":"2025-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12358044/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144875073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The penis speaks, but are we listening: the role of early trauma in understanding male sexual dysfunction. 阴茎在说话,但我们在听吗:早期创伤在理解男性性功能障碍中的作用。
IF 2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-08-15 eCollection Date: 2025-08-01 DOI: 10.1093/sexmed/qfaf058
Daniel N Watter
{"title":"The penis speaks, but are we listening: the role of early trauma in understanding male sexual dysfunction.","authors":"Daniel N Watter","doi":"10.1093/sexmed/qfaf058","DOIUrl":"10.1093/sexmed/qfaf058","url":null,"abstract":"","PeriodicalId":21782,"journal":{"name":"Sexual Medicine","volume":"13 4","pages":"qfaf058"},"PeriodicalIF":2.0,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12355174/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144875074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: The efficacy of combination therapy with Ningmitai capsule and sildenafil in men with chronic prostatitis/chronic pelvic pain syndrome and erectile dysfunction: a prospective, multicenter, randomized controlled trial. 宁米泰胶囊联合西地那非治疗慢性前列腺炎/慢性盆腔痛综合征并勃起功能障碍的疗效:一项前瞻性、多中心、随机对照试验。
IF 2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-08-13 eCollection Date: 2025-08-01 DOI: 10.1093/sexmed/qfaf063

[This corrects the article DOI: 10.1093/sexmed/qfaf024.].

[这更正了文章DOI: 10.1093/sexmed/qfaf024.]。
{"title":"Correction to: The efficacy of combination therapy with Ningmitai capsule and sildenafil in men with chronic prostatitis/chronic pelvic pain syndrome and erectile dysfunction: a prospective, multicenter, randomized controlled trial.","authors":"","doi":"10.1093/sexmed/qfaf063","DOIUrl":"https://doi.org/10.1093/sexmed/qfaf063","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1093/sexmed/qfaf024.].</p>","PeriodicalId":21782,"journal":{"name":"Sexual Medicine","volume":"13 4","pages":"qfaf063"},"PeriodicalIF":2.0,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12344244/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144848988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cannabis for female orgasmic disorder/difficulty: a systematic review. 大麻治疗女性性高潮障碍/困难:系统综述。
IF 2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-08-12 eCollection Date: 2025-08-01 DOI: 10.1093/sexmed/qfaf061
Suzanne Mulvehill, Jordan Tishler
<p><strong>Background: </strong>Cannabis is increasingly recommended to treat female orgasmic disorder/difficulty (FOD/difficulty), a condition that affects up to 41% of women worldwide with no conventional medications.</p><p><strong>Aim: </strong>To systematically review the existing literature on cannabis and its impact on female orgasm function.</p><p><strong>Methods: </strong>A systematic review based on the PRISMA model evaluated the effects of cannabis on orgasm function in females with or without FOD/difficulty. Risk of bias was assessed for randomized and nonrandomized studies. Searches were conducted in PubMed, Google Scholar, Cochrane, and Embase.</p><p><strong>Outcomes: </strong>Primary outcomes focused on the impact of cannabis on female orgasm function.</p><p><strong>Results: </strong>Sixteen studies met inclusion criteria: 1 randomized controlled trial and 15 observational studies, including data from 8849 females. Most were nonrandomized designs without comparator groups and high risk of bias. Most included both sexes and reported dichotomized outcomes by sex. None excluded females with self-reported orgasm difficulty; 1 controlled for its prevalence; 1 dichotomized females by the presence or absence of orgasm difficulty; and no studies used a clinical diagnosis of FOD. Nine studies investigated cannabis use prior to sexual activity. All 9 studies cited improvements in female orgasm function, including increases in frequency, ease, intensity, quality, and/or multiorgasmic capacity. However, 1 study found cases of situational anorgasmia, and 1 reported that women had more difficulty with focus, potentially leading to orgasm difficulty. Two studies assessed general cannabis use and sexual function: 1 found no association between the frequency of cannabis use and female sexual problems, while the other noted improved orgasm and reduced dysfunction with more frequent use. Five studies examined cannabis alongside other substances, before sex or not: 1 linked inhibited orgasm to combined cannabis and alcohol use, 1 to noncannabis substances, 2 found improved orgasm function with cannabis, and 1 reported improved orgasm function and cases of inability to orgasm due to a lack of focus.</p><p><strong>Clinical implications: </strong>Cannabis appears to be a promising treatment option for FOD/difficulty.</p><p><strong>Strengths and limitations: </strong>This review found consistent evidence that cannabis improves orgasm function in females with or without FOD/difficulty. Limitations include insufficient high-quality studies and limited reporting on cannabis dosage and timing.</p><p><strong>Conclusion: </strong>FOD/difficulty should be recognized as a qualifying condition for medical cannabis use. Given the existing evidence supporting its potential efficacy, medical cannabis warrants consideration as a first-line treatment. More randomized controlled trials are needed to clarify optimal dosing, routes of administration, strain specificity, ti
背景:大麻越来越多地被推荐用于治疗女性性高潮障碍/困难(FOD/困难),这一疾病影响着全世界多达41%的没有常规药物治疗的女性。目的:对大麻及其对女性性高潮功能影响的文献进行系统综述。方法:基于PRISMA模型系统评价大麻对有或无FOD/困难女性性高潮功能的影响。对随机和非随机研究进行偏倚风险评估。检索在PubMed, b谷歌Scholar, Cochrane和Embase中进行。结果:主要结果集中于大麻对女性性高潮功能的影响。结果:16项研究符合纳入标准:1项随机对照试验和15项观察性研究,包括8849名女性的数据。大多数是没有比较组和高偏倚风险的非随机设计。大多数包括两性,并报告了按性别划分的结果。没有排除自我报告性高潮困难的女性;1控制其流行程度;1通过存在或不存在性高潮困难来区分女性;没有研究使用FOD的临床诊断。9项研究调查了性行为前的大麻使用情况。所有9项研究都提到了女性性高潮功能的改善,包括频率、放松程度、强度、质量和/或多重高潮能力的提高。然而,一项研究发现了情境性无性高潮的案例,并报告说女性更难集中注意力,这可能会导致性高潮困难。两项研究评估了大麻的一般使用和性功能:一项研究发现大麻使用频率与女性性问题之间没有关联,而另一项研究则指出,更频繁地使用大麻可以改善性高潮,减少性功能障碍。五项研究将大麻和其他物质一起,在性行为前或不性行为前进行了检查:一项研究将抑制性高潮与大麻和酒精的结合使用联系起来,一项研究与非大麻物质有关,两项研究发现大麻可以改善性高潮功能,一项研究报告了性高潮功能的改善,以及由于缺乏注意力而无法达到性高潮的情况。临床意义:大麻似乎是FOD/困难的一种有希望的治疗选择。优势和局限性:本综述发现一致的证据表明,大麻可以改善有或没有FOD/困难的女性的性高潮功能。限制包括缺乏高质量的研究和关于大麻剂量和时间的有限报告。结论:应将FOD/困难视为医用大麻使用的合格条件。鉴于现有证据支持其潜在功效,医用大麻值得考虑作为一线治疗手段。需要更多的随机对照试验来阐明最佳剂量、给药途径、菌株特异性、使用时间以及不同FOD亚型的不同效果。
{"title":"Cannabis for female orgasmic disorder/difficulty: a systematic review.","authors":"Suzanne Mulvehill, Jordan Tishler","doi":"10.1093/sexmed/qfaf061","DOIUrl":"10.1093/sexmed/qfaf061","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Cannabis is increasingly recommended to treat female orgasmic disorder/difficulty (FOD/difficulty), a condition that affects up to 41% of women worldwide with no conventional medications.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Aim: &lt;/strong&gt;To systematically review the existing literature on cannabis and its impact on female orgasm function.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A systematic review based on the PRISMA model evaluated the effects of cannabis on orgasm function in females with or without FOD/difficulty. Risk of bias was assessed for randomized and nonrandomized studies. Searches were conducted in PubMed, Google Scholar, Cochrane, and Embase.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Outcomes: &lt;/strong&gt;Primary outcomes focused on the impact of cannabis on female orgasm function.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Sixteen studies met inclusion criteria: 1 randomized controlled trial and 15 observational studies, including data from 8849 females. Most were nonrandomized designs without comparator groups and high risk of bias. Most included both sexes and reported dichotomized outcomes by sex. None excluded females with self-reported orgasm difficulty; 1 controlled for its prevalence; 1 dichotomized females by the presence or absence of orgasm difficulty; and no studies used a clinical diagnosis of FOD. Nine studies investigated cannabis use prior to sexual activity. All 9 studies cited improvements in female orgasm function, including increases in frequency, ease, intensity, quality, and/or multiorgasmic capacity. However, 1 study found cases of situational anorgasmia, and 1 reported that women had more difficulty with focus, potentially leading to orgasm difficulty. Two studies assessed general cannabis use and sexual function: 1 found no association between the frequency of cannabis use and female sexual problems, while the other noted improved orgasm and reduced dysfunction with more frequent use. Five studies examined cannabis alongside other substances, before sex or not: 1 linked inhibited orgasm to combined cannabis and alcohol use, 1 to noncannabis substances, 2 found improved orgasm function with cannabis, and 1 reported improved orgasm function and cases of inability to orgasm due to a lack of focus.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Clinical implications: &lt;/strong&gt;Cannabis appears to be a promising treatment option for FOD/difficulty.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Strengths and limitations: &lt;/strong&gt;This review found consistent evidence that cannabis improves orgasm function in females with or without FOD/difficulty. Limitations include insufficient high-quality studies and limited reporting on cannabis dosage and timing.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;FOD/difficulty should be recognized as a qualifying condition for medical cannabis use. Given the existing evidence supporting its potential efficacy, medical cannabis warrants consideration as a first-line treatment. More randomized controlled trials are needed to clarify optimal dosing, routes of administration, strain specificity, ti","PeriodicalId":21782,"journal":{"name":"Sexual Medicine","volume":"13 4","pages":"qfaf061"},"PeriodicalIF":2.0,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12343064/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144848987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Difficulties in emotion regulation, repetitive negative thinking, and sexual and psychological distress: a two-wave longitudinal mediation study using a transdiagnostic approach. 情绪调节困难、重复消极思维、性和心理困扰:一项采用跨诊断方法的双波纵向中介研究。
IF 2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-08-11 eCollection Date: 2025-08-01 DOI: 10.1093/sexmed/qfaf052
Catarina F Raposo, Pedro J Nobre, Pedro J Rosa, Patrícia M Pascoal

Background: Sexual distress is a critical element in diagnosing sexual dysfunction. Recent research using a cross-sectional design has supported the adequacy of a transdiagnostic approach for its understanding.

Aim: This exploratory study aimed to investigate the mediating role of repetitive negative thinking between difficulties in emotional regulation and sexual and psychological distress in a community sample.

Methods: We used a quantitative longitudinal design with measures including a sociodemographic questionnaire, the Difficulties in Emotion Regulation Scale-Short Form, the Persistent and Intrusive Negative Thoughts Scale, the Sexual Distress Scale-Revised, and the Kessler Psychological Distress Scale.

Outcomes: Data were collected from 64 partnered individuals (85.9% women; age: M = 31.20, SD = 6.46).

Results: Correlational analysis across time revealed significant associations among difficulties in emotion regulation (T1 r = 0.37, T2 r = 0.32), repetitive negative thinking (T1 r = 0.30, T2 r = 0.27), psychological distress (T1 r = 0.37, T2 r = 0.55), and sexual distress (all at P < .01)​. The total effect of difficulties in emotion regulation on sexual distress was found to be positive (β = 0.20, P = .008) after controlling for frequency of sexual activity (r = -0.25, P < .05). Longitudinal mediation analysis indicated a significant negative indirect effect from difficulties in emotion regulation on sexual distress via repetitive negative thinking (β = -0.04, 95% CI [-0.008, -0.001]), suggesting a buffering effect over time on sexual distress.

Clinical implications: These results highlight the significance of recognizing difficulties in emotion regulation and repetitive negative thinking as coping strategies when examining sexual distress, emphasizing the need to explore the putative efficacy of therapeutic interventions focused on addressing these cognitive processes to decrease adverse sexual-related outcomes.

Strengths and limitations: These findings highlight the importance of acknowledging difficulties in emotion regulation and repetitive negative thinking as coping strategies in the study of sexual distress. However, the small sample size and the predominance of women participants limit generalizability. Further research with clinical samples and more diverse populations is needed to better understand the relevance of these aspects in assessment and therapy.

Conclusions: The findings imply that repetitive negative thinking may have potentially adaptive effects, indicating a nuanced role in coping strategies within the context of the study.

背景:性困扰是诊断性功能障碍的关键因素。最近使用横断面设计的研究支持跨诊断方法对其理解的充分性。目的:探讨重复性消极思维在社区情绪调节困难与性心理困扰之间的中介作用。方法:采用纵向定量设计,包括社会人口学问卷、情绪调节困难简易量表、持续性和侵入性消极思想量表、性困扰量表(修订版)和Kessler心理困扰量表。结果:收集了64名伴侣的数据(85.9%为女性;年龄:M = 31.20, SD = 6.46)。结果:在控制性活动频率(r = -0.25, P)后,情绪调节困难(T1 r = 0.37, T2 r = 0.32)、重复性消极思维(T1 r = 0.30, T2 r = 0.27)、心理困扰(T1 r = 0.37, T2 r = 0.55)和性困扰(P均为P = 0.008)具有显著相关性。这些结果强调了在检查性困扰时认识到情绪调节困难和重复消极思维作为应对策略的重要性,强调了探索治疗干预措施的假定功效的必要性,这些干预措施侧重于解决这些认知过程,以减少不良的性相关结果。优势和局限性:这些发现强调了承认情绪调节困难和重复消极思维作为应对策略在性困扰研究中的重要性。然而,小样本量和女性参与者的优势限制了普遍性。需要对临床样本和更多样化的人群进行进一步研究,以更好地了解这些方面在评估和治疗中的相关性。结论:研究结果表明,重复的消极思维可能具有潜在的适应性效应,表明在研究背景下应对策略的微妙作用。
{"title":"Difficulties in emotion regulation, repetitive negative thinking, and sexual and psychological distress: a two-wave longitudinal mediation study using a transdiagnostic approach.","authors":"Catarina F Raposo, Pedro J Nobre, Pedro J Rosa, Patrícia M Pascoal","doi":"10.1093/sexmed/qfaf052","DOIUrl":"10.1093/sexmed/qfaf052","url":null,"abstract":"<p><strong>Background: </strong>Sexual distress is a critical element in diagnosing sexual dysfunction. Recent research using a cross-sectional design has supported the adequacy of a transdiagnostic approach for its understanding.</p><p><strong>Aim: </strong>This exploratory study aimed to investigate the mediating role of repetitive negative thinking between difficulties in emotional regulation and sexual and psychological distress in a community sample.</p><p><strong>Methods: </strong>We used a quantitative longitudinal design with measures including a sociodemographic questionnaire, the Difficulties in Emotion Regulation Scale-Short Form, the Persistent and Intrusive Negative Thoughts Scale, the Sexual Distress Scale-Revised, and the Kessler Psychological Distress Scale.</p><p><strong>Outcomes: </strong>Data were collected from 64 partnered individuals (85.9% women; age: M = 31.20, SD = 6.46).</p><p><strong>Results: </strong>Correlational analysis across time revealed significant associations among difficulties in emotion regulation (T1 <i>r</i> = 0.37, T2 <i>r</i> = 0.32), repetitive negative thinking (T1 <i>r</i> = 0.30, T2 <i>r</i> = 0.27), psychological distress (T1 <i>r</i> = 0.37, T2 <i>r</i> = 0.55), and sexual distress (all at <i>P</i> < .01)​. The total effect of difficulties in emotion regulation on sexual distress was found to be positive (β = 0.20, <i>P</i> = .008) after controlling for frequency of sexual activity (<i>r</i> = -0.25, <i>P</i> < .05). Longitudinal mediation analysis indicated a significant negative indirect effect from difficulties in emotion regulation on sexual distress via repetitive negative thinking (β = -0.04, 95% CI [-0.008, -0.001]), suggesting a buffering effect over time on sexual distress.</p><p><strong>Clinical implications: </strong>These results highlight the significance of recognizing difficulties in emotion regulation and repetitive negative thinking as coping strategies when examining sexual distress, emphasizing the need to explore the putative efficacy of therapeutic interventions focused on addressing these cognitive processes to decrease adverse sexual-related outcomes.</p><p><strong>Strengths and limitations: </strong>These findings highlight the importance of acknowledging difficulties in emotion regulation and repetitive negative thinking as coping strategies in the study of sexual distress. However, the small sample size and the predominance of women participants limit generalizability. Further research with clinical samples and more diverse populations is needed to better understand the relevance of these aspects in assessment and therapy.</p><p><strong>Conclusions: </strong>The findings imply that repetitive negative thinking may have potentially adaptive effects, indicating a nuanced role in coping strategies within the context of the study.</p>","PeriodicalId":21782,"journal":{"name":"Sexual Medicine","volume":"13 4","pages":"qfaf052"},"PeriodicalIF":2.0,"publicationDate":"2025-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12342931/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144849002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pelvic floor physical therapy in the treatment of a patient with persistent genital arousal disorder/genito-pelvic dysesthesia: a case report. 盆底物理疗法治疗持续性生殖器觉醒障碍/生殖器-盆腔感觉障碍1例
IF 2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-08-11 eCollection Date: 2025-08-01 DOI: 10.1093/sexmed/qfaf057
Tangdi Lin, Wenjia Lou, Guorong Fan, Lina Niu, Lan Zhu

Introduction: Persistent genital arousal disorder/genito-pelvic dysesthesia (PGAD/GPD) is a condition of persistent or recurrent, unwanted or intrusive sensation of genital arousal that is usually associated with a distressing feeling and has a great impact on patients' daily life. Pelvic floor physical therapy is one of the effective conservative treatment options that deserves increased attention.

Aims: This case report aims to provide a comprehensive pelvic floor physical therapy evaluation and treatment plans for a patient with PGAD/GPD that resulted in a complete resolution of symptoms.

Methods: The patient is a 63-year-old female who suffered from persistent and uncontrolled sexual arousal over 3 months. Despite her efforts, the symptoms gradually worsened and never completely resolved, resulting in significant distress and despair. Her examination findings include myofascial restrictions on superficial pelvic floor structures, hypertonic pelvic floor muscles with trigger points, radiating pain along with genitofemoral nerve innervated areas, and lack of pelvic floor muscle strength and coordination. Physical therapy treatment plan included patient education, manual therapy, muscle strengthening exercises, and home exercise programs.

Results: The patient's symptoms were completely resolved after a total of four pelvic floor physical therapy sessions. Home exercise program was able to maintain satisfactory treatment outcomes 3 months post treatment. No complaints were reported at the 6-month and 1-year follow-ups.

Conclusion: Genitofemoral nerve pathology may be a potential etiology for PGAD/GPD. Pelvic floor physical therapy can an effective medical treatment for PGAD/GPD originating from the pelvic and perineum region. A comprehensive pelvic floor examination and an evidence-based treatment plan will be able to improve symptoms and potentially resolve them completely.

简介:持续性生殖器觉醒障碍/生殖盆腔感觉障碍(PGAD/GPD)是一种持续或反复出现的、不想要的或侵入性的生殖器觉醒感觉,通常伴有痛苦的感觉,对患者的日常生活有很大的影响。盆底物理治疗是一种有效的保守治疗方法,值得重视。目的:本病例报告旨在为一名pad /GPD患者提供全面的盆底物理治疗评估和治疗方案,使其症状得到完全解决。方法:患者女性,63岁,持续不可控性唤起3个多月。尽管她的努力,症状逐渐恶化,从未完全解决,导致严重的痛苦和绝望。检查结果包括盆底浅表结构肌筋膜受限,伴有触发点的盆底肌肉高渗,生殖股神经支配区放射性疼痛,盆底肌肉力量和协调性缺乏。物理治疗方案包括患者教育、手工治疗、肌肉强化练习和家庭锻炼项目。结果:患者经四次盆底物理治疗后症状完全缓解。家庭锻炼方案能够在治疗后3个月保持满意的治疗效果。随访6个月和1年,无患者投诉。结论:生殖股神经病变可能是pad /GPD的潜在病因。盆底物理治疗可以有效治疗起源于盆腔和会阴区域的pad /GPD。全面的盆底检查和循证治疗计划将能够改善症状并有可能完全解决它们。
{"title":"Pelvic floor physical therapy in the treatment of a patient with persistent genital arousal disorder/genito-pelvic dysesthesia: a case report.","authors":"Tangdi Lin, Wenjia Lou, Guorong Fan, Lina Niu, Lan Zhu","doi":"10.1093/sexmed/qfaf057","DOIUrl":"10.1093/sexmed/qfaf057","url":null,"abstract":"<p><strong>Introduction: </strong>Persistent genital arousal disorder/genito-pelvic dysesthesia (PGAD/GPD) is a condition of persistent or recurrent, unwanted or intrusive sensation of genital arousal that is usually associated with a distressing feeling and has a great impact on patients' daily life. Pelvic floor physical therapy is one of the effective conservative treatment options that deserves increased attention.</p><p><strong>Aims: </strong>This case report aims to provide a comprehensive pelvic floor physical therapy evaluation and treatment plans for a patient with PGAD/GPD that resulted in a complete resolution of symptoms.</p><p><strong>Methods: </strong>The patient is a 63-year-old female who suffered from persistent and uncontrolled sexual arousal over 3 months. Despite her efforts, the symptoms gradually worsened and never completely resolved, resulting in significant distress and despair. Her examination findings include myofascial restrictions on superficial pelvic floor structures, hypertonic pelvic floor muscles with trigger points, radiating pain along with genitofemoral nerve innervated areas, and lack of pelvic floor muscle strength and coordination. Physical therapy treatment plan included patient education, manual therapy, muscle strengthening exercises, and home exercise programs.</p><p><strong>Results: </strong>The patient's symptoms were completely resolved after a total of four pelvic floor physical therapy sessions. Home exercise program was able to maintain satisfactory treatment outcomes 3 months post treatment. No complaints were reported at the 6-month and 1-year follow-ups.</p><p><strong>Conclusion: </strong>Genitofemoral nerve pathology may be a potential etiology for PGAD/GPD. Pelvic floor physical therapy can an effective medical treatment for PGAD/GPD originating from the pelvic and perineum region. A comprehensive pelvic floor examination and an evidence-based treatment plan will be able to improve symptoms and potentially resolve them completely.</p>","PeriodicalId":21782,"journal":{"name":"Sexual Medicine","volume":"13 4","pages":"qfaf057"},"PeriodicalIF":2.0,"publicationDate":"2025-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12342909/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144849004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hinokiflavone alleviates high-fat diet-induced erectile dysfunction via the EGFR/PI3K/Akt/eNOS signaling pathway. Hinokiflavone通过EGFR/PI3K/Akt/eNOS信号通路缓解高脂肪饮食诱导的勃起功能障碍。
IF 2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-08-06 eCollection Date: 2025-08-01 DOI: 10.1093/sexmed/qfaf059
Peng-Chao Gao, Xiao-Hui Tan, Man-Cheng Xia, Ke-Fan Li, Fang-Zhou Zhao, Hong-Gang Ying, Zhuo Zhou, Yi-Ming Yuan, Tie-Gui Nan, Rui-Li Guan

Background: Erectile dysfunction (ED) is a significant health issue affecting the global male population, with a complex and multifaceted etiology. High-fat diet (HFD) is known to impair endothelial function and promote the development of ED. Hinokiflavone (HINO), a naturally occurring biflavonoid, has garnered attention for its notable antioxidant and anti-inflammatory activities, suggesting its potential therapeutic role in treating ED.

Aim: This study aims to investigate the therapeutic effects and underlying mechanisms of HINO in HFD-induced ED.

Methods: Network pharmacology and molecular dynamics simulation were employed to predict relevant targets and analyze their binding kinetics. Rat corpus cavernosum endothelial cells (RCCECs) were treated with palmitic acid in vitro to induce metabolic dysfunction. The ED model was established in vivo by feeding male rats an HFD (60 kcal% fat).

Outcomes: The primary outcomes were the target genes and pathways associated with HINO and the evaluation of its therapeutic potential in HFD-induced ED.

Results: Bioinformatics analyses identified the epidermal growth factor receptor (EGFR) and protein kinase B (Akt) as key molecular targets of HINO. Treatment with HINO promoted RCCEC proliferation, enhanced antioxidant activities, and increased nitric oxide production. The administration of HINO ameliorated erectile dysfunction, improved serum lipid profiles, and reduced oxidative stress in HFD-fed rats. The protective effects of HINO against endothelial dysfunction and impaired cell viability were mediated through modulation of the EGFR/PI3K/Akt/eNOS signaling pathway.

Clinical translation: The results provide a strong rationale for further investigation of HINO as a novel therapeutic agent for ED, with promising implications for future clinical applications.

Strengths and limitations: In this study, we found that HINO could mitigate HFD-induced ED. Limitations of the study include that the alternative mechanisms of HINO were not fully explored in these settings.

Conclusions: Our findings underscore the pharmacological properties of HINO in the management of ED, particularly through the modulation of critical targets such as EGFR.

背景:勃起功能障碍(ED)是影响全球男性人口的一个重要健康问题,具有复杂和多方面的病因。高脂肪饮食(HFD)会损害内皮功能,促进ED的发生。Hinokiflavone (HINO)是一种天然存在的双类黄酮,因其显著的抗氧化和抗炎活性而受到关注,提示其在ED的治疗中具有潜在的治疗作用。目的:本研究旨在探讨HINO对HFD诱导ED的治疗作用及其机制。采用网络药理学和分子动力学模拟方法预测相关靶点并分析其结合动力学。用棕榈酸处理大鼠海绵体内皮细胞(RCCECs),诱导其体外代谢功能障碍。通过给雄性大鼠喂食HFD (60 kcal%脂肪)建立ED模型。结果:主要结果是与HINO相关的靶基因和通路,以及对其治疗hfd诱导ed的潜力的评估。结果:生物信息学分析确定了表皮生长因子受体(EGFR)和蛋白激酶B (Akt)是HINO的关键分子靶点。HINO处理促进RCCEC增殖,增强抗氧化活性,增加一氧化氮的产生。在饲喂hfd的大鼠中,HINO改善了勃起功能障碍,改善了血清脂质谱,并降低了氧化应激。HINO对内皮功能障碍和细胞活力受损的保护作用是通过调节EGFR/PI3K/Akt/eNOS信号通路介导的。临床翻译:该结果为进一步研究HINO作为ED的新型治疗剂提供了强有力的理论依据,对未来的临床应用具有重要意义。优势和局限性:在本研究中,我们发现HINO可以减轻hfd诱导的ED。该研究的局限性包括HINO的替代机制没有在这些环境中得到充分的探索。结论:我们的研究结果强调了HINO在ED治疗中的药理学特性,特别是通过调节关键靶点如EGFR。
{"title":"Hinokiflavone alleviates high-fat diet-induced erectile dysfunction via the EGFR/PI3K/Akt/eNOS signaling pathway.","authors":"Peng-Chao Gao, Xiao-Hui Tan, Man-Cheng Xia, Ke-Fan Li, Fang-Zhou Zhao, Hong-Gang Ying, Zhuo Zhou, Yi-Ming Yuan, Tie-Gui Nan, Rui-Li Guan","doi":"10.1093/sexmed/qfaf059","DOIUrl":"10.1093/sexmed/qfaf059","url":null,"abstract":"<p><strong>Background: </strong>Erectile dysfunction (ED) is a significant health issue affecting the global male population, with a complex and multifaceted etiology. High-fat diet (HFD) is known to impair endothelial function and promote the development of ED. Hinokiflavone (HINO), a naturally occurring biflavonoid, has garnered attention for its notable antioxidant and anti-inflammatory activities, suggesting its potential therapeutic role in treating ED.</p><p><strong>Aim: </strong>This study aims to investigate the therapeutic effects and underlying mechanisms of HINO in HFD-induced ED.</p><p><strong>Methods: </strong>Network pharmacology and molecular dynamics simulation were employed to predict relevant targets and analyze their binding kinetics. Rat corpus cavernosum endothelial cells (RCCECs) were treated with palmitic acid <i>in vitro</i> to induce metabolic dysfunction. The ED model was established <i>in vivo</i> by feeding male rats an HFD (60 kcal% fat).</p><p><strong>Outcomes: </strong>The primary outcomes were the target genes and pathways associated with HINO and the evaluation of its therapeutic potential in HFD-induced ED.</p><p><strong>Results: </strong>Bioinformatics analyses identified the epidermal growth factor receptor (EGFR) and protein kinase B (Akt) as key molecular targets of HINO. Treatment with HINO promoted RCCEC proliferation, enhanced antioxidant activities, and increased nitric oxide production. The administration of HINO ameliorated erectile dysfunction, improved serum lipid profiles, and reduced oxidative stress in HFD-fed rats. The protective effects of HINO against endothelial dysfunction and impaired cell viability were mediated through modulation of the EGFR/PI3K/Akt/eNOS signaling pathway.</p><p><strong>Clinical translation: </strong>The results provide a strong rationale for further investigation of HINO as a novel therapeutic agent for ED, with promising implications for future clinical applications.</p><p><strong>Strengths and limitations: </strong>In this study, we found that HINO could mitigate HFD-induced ED. Limitations of the study include that the alternative mechanisms of HINO were not fully explored in these settings.</p><p><strong>Conclusions: </strong>Our findings underscore the pharmacological properties of HINO in the management of ED, particularly through the modulation of critical targets such as EGFR.</p>","PeriodicalId":21782,"journal":{"name":"Sexual Medicine","volume":"13 4","pages":"qfaf059"},"PeriodicalIF":2.0,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12341904/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144849003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Are obstetrics and gynecology residents sexually satisfied? 妇产科住院医师对性生活满意吗?
IF 2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-08-05 eCollection Date: 2025-08-01 DOI: 10.1093/sexmed/qfaf026
Natasha Kamat, Sheryl Kingsberg, Erika Kelley

Background: There is a dearth of data on the impact of residency on resident sexual health. What exists utilizes the Female Sexual Function Index (FSFI) and the International Index of Erectile Function (IIEF), which primarily assess function and often refer to sexual activity as penetrative sexual intercourse. This presents a limited view on sexual activity and sexuality.

Aim: The objective of this study was to evaluate the effect of obstetrics and gynecology (OBGYN) residency on resident sexual satisfaction using the gender and relationship neutral New Sexual Satisfaction Scale (NSSS).

Methods: Between July 2022 and August 2023, 137 current US OBGYN residents were recruited and completed questionnaires at three timepoints (baseline, 6 months, and 12 months) assessing their demographic data, city and level of training, work hours, gender identity, sexual orientation, relationship status, and the NSSS.

Outcomes: We hypothesized that OBGYN residents in later years of residency would report lower sexual satisfaction than post graduate year one residents (PGY-1 s) and that sexual satisfaction would decrease later in OBGYN residency due to the cumulative effect of work stress.

Results: There was a significant increase in NSSS total scores from baseline (M = 67.5) to 12 month follow-up (M = 72.1) in all residents. However, when the sample was stratified by year of residency, postgraduate year one residents (PGY-1 s) had a decrease in their NSSS total and subscale scores over time as compared to postgraduate year two residents and above who had an overall increase in their NSSS total and subscale scores over time.

Clinical implications: This data presents evidence to support initiatives by OBGYN residency programs to support sexual health and resilience training and opens avenues for further research into sexual satisfaction in other medical subspecialities.

Strengths & limitations: Strengths include utilizing a validated, gender neutral survey. Limitations include small sample size and opt-in study design.

Conclusion: The increase in sexual satisfaction in later years of OBGYN residency may be due to increased resilience over the course of residency. However, the unique stress of the transition from medical school to residency may be highlighted in the decrease in sexual satisfaction scores over time demonstrated in the PGY-1 s.

背景:居住对居民性健康影响的数据缺乏。现有的方法是使用女性性功能指数(FSFI)和国际勃起功能指数(IIEF),它们主要评估性功能,通常将性活动称为插入性行为。这是对性活动和性行为的一种有限的看法。目的:本研究采用性别与关系中性的新型性满意度量表(NSSS),探讨妇产科住院医师对住院医师性满意度的影响。方法:在2022年7月至2023年8月期间,招募了137名美国OBGYN现有居民,并在三个时间点(基线,6个月和12个月)完成问卷调查,评估他们的人口统计数据,城市和培训水平,工作时间,性别认同,性取向,关系状况和NSSS。结果:我们假设在后期实习的妇产科住院医师的性满意度低于研究生一年级实习医师(PGY-1 s),并且由于工作压力的累积效应,在后期实习的妇产科住院医师的性满意度会下降。结果:从基线(M = 67.5)到12个月随访(M = 72.1),所有住院患者的NSSS总分显著增加。然而,当样本按居住年份分层时,与研究生二年及以上的住院医师相比,研究生一年级住院医师(PGY-1 s)的NSSS总分数和子量表分数随时间的推移而下降,而研究生二年级及以上的住院医师的NSSS总分数和子量表分数随时间的推移而总体上升。临床意义:该数据为妇产科住院医师项目提供了支持性健康和恢复力培训的证据,并为进一步研究其他医学专科的性满意度开辟了道路。优势和局限性:优势包括使用有效的、性别中立的调查。局限性包括样本量小和选择性研究设计。结论:在妇产科住院治疗的后期,性满意度的提高可能是由于住院治疗过程中心理弹性的增强。然而,PGY-1所显示的性满意度分数随着时间的推移而下降,可能突出了从医学院过渡到住院医师的独特压力。
{"title":"Are obstetrics and gynecology residents sexually satisfied?","authors":"Natasha Kamat, Sheryl Kingsberg, Erika Kelley","doi":"10.1093/sexmed/qfaf026","DOIUrl":"10.1093/sexmed/qfaf026","url":null,"abstract":"<p><strong>Background: </strong>There is a dearth of data on the impact of residency on resident sexual health. What exists utilizes the Female Sexual Function Index (FSFI) and the International Index of Erectile Function (IIEF), which primarily assess function and often refer to sexual activity as penetrative sexual intercourse. This presents a limited view on sexual activity and sexuality.</p><p><strong>Aim: </strong>The objective of this study was to evaluate the effect of obstetrics and gynecology (OBGYN) residency on resident sexual satisfaction using the gender and relationship neutral New Sexual Satisfaction Scale (NSSS).</p><p><strong>Methods: </strong>Between July 2022 and August 2023, 137 current US OBGYN residents were recruited and completed questionnaires at three timepoints (baseline, 6 months, and 12 months) assessing their demographic data, city and level of training, work hours, gender identity, sexual orientation, relationship status, and the NSSS.</p><p><strong>Outcomes: </strong>We hypothesized that OBGYN residents in later years of residency would report lower sexual satisfaction than post graduate year one residents (PGY-1 s) and that sexual satisfaction would decrease later in OBGYN residency due to the cumulative effect of work stress.</p><p><strong>Results: </strong>There was a significant increase in NSSS total scores from baseline (<i>M</i> = 67.5) to 12 month follow-up (<i>M</i> = 72.1) in all residents. However, when the sample was stratified by year of residency, postgraduate year one residents (PGY-1 s) had a decrease in their NSSS total and subscale scores over time as compared to postgraduate year two residents and above who had an overall increase in their NSSS total and subscale scores over time.</p><p><strong>Clinical implications: </strong>This data presents evidence to support initiatives by OBGYN residency programs to support sexual health and resilience training and opens avenues for further research into sexual satisfaction in other medical subspecialities.</p><p><strong>Strengths & limitations: </strong>Strengths include utilizing a validated, gender neutral survey. Limitations include small sample size and opt-in study design.</p><p><strong>Conclusion: </strong>The increase in sexual satisfaction in later years of OBGYN residency may be due to increased resilience over the course of residency. However, the unique stress of the transition from medical school to residency may be highlighted in the decrease in sexual satisfaction scores over time demonstrated in the PGY-1 s.</p>","PeriodicalId":21782,"journal":{"name":"Sexual Medicine","volume":"13 4","pages":"qfaf026"},"PeriodicalIF":2.0,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12358247/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144883589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Sexual Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1